Neoteryx LLC recently announced that it will supply its Volumetric Absorptive Microsampling (VAMS™) technology, in the form of the Mitra® microsampling device, to Alcala Labs of San Diego for a more efficacious, streamlined approach to monitor patients in recovery centers throughout the United States.
All news from Anaesthesiology
Researchers determine that light exposure and mealtime may be the key to resetting the "master clock” in the brain. In casual conversation, the “biological clock” is often referred to when starting a family but officially, our biological clocks, or our circadian rhythms, are how our bodies know when to go to sleep at night and when to wake up in the morning.
With a few notable exceptions, most of us live lives in which we work at day and sleep at night, loosely following the rise and setting of the sun. However, as any insomniac can tell you, it’s also super easy for our circadian rhythms to go off-kilter.
In 2016, funded by a $16 million grant from Scythian, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD (a cannabinoid derivative of hemp) with an NMDA antagonist (an anesthetic used in animals and humans) for the treatment of traumatic brain injury and concussion. The researchers believed the combination could reduce post-injury brain cell inflammation, headache, pain and other symptoms associated with concussion.
The uniqueness of SUSU scientists' development consists in the fact that this device, unlike other analogous devices, allows involving all the joints of lower limb. Patented know-how can be applied not only for rehabilitation after serious injuries or teaching children with infantile cerebral palsy to walk but also for optimization of sportsmen' technique.
A majority of registered voters oppose recent efforts to scale back Supplemental Nutrition Assistance Program (SNAP) food benefits and believe the government should be doing more to meet the needs of people facing food insecurity and other challenges, according to a new survey commissioned by the Johns Hopkins Bloomberg School of Public Health's Center for a Livable Future (CLF).
Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). In the classroom, parents and teachers say that medications like methylphenidate (MPH) can reduce symptoms and improve behavior.
Although stimulants have been in use for decades to treat ADHD in school-aged children, just how they work hasn't been clear. The new study in the Journal of Child Psychology and Psychiatry is filling in critical gaps about the role of improved cognitive functions.
Dr. Nick Nelson walks through busy Highland Hospital to a sixth-floor exam room, where he sees patients from around the world who say they have fled torture and violence.
Dr. Kenneth Alexander was driving home one day last year when he thought of the idea: What if the Zika virus could be used to kill a childhood cancer called neuroblastoma?
The study, of 300 heart patients with depression, found that treatment with the antidepressant escitalopram (Lexapro) almost halved the risk of suffering another heart attack in the next eight years. It's common for heart attack survivors to develop depression. Now a new trial has found that antidepressant treatment may help those patients avoid a second heart attack.
Patients on the medication also had a lower death rate and less need for angioplasty a procedure that opens blocked heart arteries. When someone has a heart attack, heart surgery or stroke, the immediate concern obviously is physical health. The study was published in the Journal of the American Medical Association.
The incidence of tick-borne infections in the United States has risen significantly within the past decade. It is imperative, therefore, that public health officials and scientists build a robust understanding of pathogenesis, design improved diagnostics, and develop preventive vaccines, according to a new commentary in the New England Journal of Medicine.
Diseases such as cancer, heart disease and stroke are deadlier in the developing world than in rich nations. This is the finding of a new analysis from researchers at Imperial College London.
Zika virus (ZIKV) may be sexually transmissible for a shorter period than previously estimated, according to a systematic review published in PLOS Medicine by Michel Counotte and Nicola Low of the University of Bern in Switzerland, and colleagues from the World Health Organization, US Centers for Disease Control and National Institute of Allergy and Infectious Disease. The review included analysis of data from both human and animal studies and was conducted to describe the epidemiology of sexual transmission of ZIKV.